Eledon Pharmaceuticals Stock Price History
| ELDN Stock | USD 1.99 0.42 26.75% |
Below is the normalized historical share price chart for Eledon Pharmaceuticals extending back to September 17, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eledon Pharmaceuticals stands at 1.99, as last reported on the 18th of April 2024, with the highest price reaching 2.00 and the lowest price hitting 1.55 during the day.
If you're considering investing in Eledon Stock, it is important to understand the factors that can impact its price. Eledon Pharmaceuticals appears to be moderately volatile, given 3 months investment horizon. Eledon Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0782, which denotes the company had a 0.0782% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Eledon Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please utilize Eledon Pharmaceuticals' Mean Deviation of 2.95, standard deviation of 3.84, and Variance of 14.73 to check if our risk estimates are consistent with your expectations.
As of the 18th of April 2024, Common Stock Shares Outstanding is likely to grow to about 25.9 M, while Total Stockholder Equity is likely to drop about 60.7 M. . At this time, Eledon Pharmaceuticals' Price Book Value Ratio is very stable compared to the past year. As of the 18th of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.02, while Price To Sales Ratio is likely to drop 149.02. Eledon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of September 2014 | 200 Day MA 1.5131 | 50 Day MA 1.7702 | Beta 0.929 |
Eledon |
Sharpe Ratio = 0.0782
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ELDN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.12 actual daily | 45 55% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Eledon Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eledon Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.5027 | Book Value 3.445 | Enterprise Value -11 M | Enterprise Value Ebitda 0.2061 | Shares Float 18 M |
Eledon Pharmaceuticals Stock Price History Chart
There are several ways to analyze Eledon Stock price data. The simplest method is using a basic Eledon candlestick price chart, which shows Eledon Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 27, 2024 | 2.13 |
| Lowest Price | March 15, 2024 | 1.54 |
Eledon Pharmaceuticals April 18, 2024 Stock Price Synopsis
Various analyses of Eledon Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Eledon Stock. It can be used to describe the percentage change in the price of Eledon Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Eledon Stock.| Eledon Pharmaceuticals Price Daily Balance Of Power | 0.93 | |
| Eledon Pharmaceuticals Accumulation Distribution | 77,000 | |
| Eledon Pharmaceuticals Price Action Indicator | 0.42 | |
| Eledon Pharmaceuticals Price Rate Of Daily Change | 1.27 |
Eledon Pharmaceuticals April 18, 2024 Stock Price Analysis
Eledon Stock Price History Data
The price series of Eledon Pharmaceuticals for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 has a statistical range of 0.59 with a coefficient of variation of 7.26. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.76. The median price for the last 90 days is 1.74. The company completed 1:18 stock split on 5th of October 2020. Eledon Pharmaceuticals completed dividends distribution on 2020-10-05.| Open | High | Low | Close | Volume | ||
| 04/18/2024 | 1.55 | 2.00 | 1.55 | 1.99 | 342,220 | |
| 04/17/2024 | 1.58 | 1.68 | 1.55 | 1.57 | 12,526 | |
| 04/16/2024 | 1.64 | 1.67 | 1.56 | 1.60 | 16,779 | |
| 04/15/2024 | 1.64 | 1.69 | 1.52 | 1.64 | 69,545 | |
| 04/12/2024 | 1.65 | 1.73 | 1.56 | 1.69 | 32,234 | |
| 04/11/2024 | 1.70 | 1.76 | 1.62 | 1.66 | 43,680 | |
| 04/10/2024 | 1.66 | 1.77 | 1.65 | 1.68 | 45,293 | |
| 04/09/2024 | 1.74 | 1.77 | 1.54 | 1.66 | 49,184 | |
| 04/08/2024 | 1.72 | 1.75 | 1.68 | 1.73 | 21,671 | |
| 04/05/2024 | 1.76 | 1.78 | 1.66 | 1.72 | 198,092 | |
| 04/04/2024 | 1.73 | 1.80 | 1.72 | 1.76 | 98,955 | |
| 04/03/2024 | 1.92 | 1.92 | 1.67 | 1.69 | 173,121 | |
| 04/02/2024 | 2.00 | 2.00 | 1.85 | 1.93 | 65,208 | |
| 04/01/2024 | 2.10 | 2.10 | 1.90 | 1.99 | 107,542 | |
| 03/28/2024 | 2.17 | 2.17 | 2.04 | 2.06 | 45,345 | |
| 03/27/2024 | 2.12 | 2.18 | 2.00 | 2.13 | 102,509 | |
| 03/26/2024 | 2.04 | 2.14 | 1.99 | 2.12 | 97,687 | |
| 03/25/2024 | 2.23 | 2.23 | 1.98 | 2.07 | 131,154 | |
| 03/22/2024 | 2.07 | 2.21 | 1.95 | 2.01 | 613,528 | |
| 03/21/2024 | 1.66 | 1.92 | 1.66 | 1.88 | 529,846 | |
| 03/20/2024 | 1.62 | 1.69 | 1.61 | 1.69 | 14,937 | |
| 03/19/2024 | 1.62 | 1.73 | 1.61 | 1.62 | 20,928 | |
| 03/18/2024 | 1.59 | 1.67 | 1.53 | 1.62 | 38,542 | |
| 03/15/2024 | 1.60 | 1.64 | 1.52 | 1.54 | 55,751 | |
| 03/14/2024 | 1.70 | 1.70 | 1.57 | 1.60 | 31,037 | |
| 03/13/2024 | 1.62 | 1.79 | 1.62 | 1.67 | 29,368 | |
| 03/12/2024 | 1.76 | 1.79 | 1.62 | 1.63 | 80,066 | |
| 03/11/2024 | 1.70 | 1.76 | 1.60 | 1.73 | 51,473 | |
| 03/08/2024 | 1.71 | 1.72 | 1.67 | 1.67 | 31,238 | |
| 03/07/2024 | 1.71 | 1.74 | 1.67 | 1.72 | 30,365 | |
| 03/06/2024 | 1.68 | 1.71 | 1.65 | 1.71 | 10,286 | |
| 03/05/2024 | 1.65 | 1.73 | 1.61 | 1.64 | 32,717 | |
| 03/04/2024 | 1.70 | 1.78 | 1.63 | 1.66 | 69,084 | |
| 03/01/2024 | 1.84 | 1.85 | 1.55 | 1.61 | 176,960 | |
| 02/29/2024 | 1.88 | 1.88 | 1.80 | 1.80 | 102,880 | |
| 02/28/2024 | 1.87 | 1.88 | 1.82 | 1.84 | 72,630 | |
| 02/27/2024 | 1.90 | 1.90 | 1.80 | 1.83 | 39,010 | |
| 02/26/2024 | 1.91 | 1.91 | 1.80 | 1.83 | 42,407 | |
| 02/23/2024 | 1.88 | 1.88 | 1.80 | 1.88 | 25,668 | |
| 02/22/2024 | 1.82 | 1.89 | 1.82 | 1.82 | 24,358 | |
| 02/21/2024 | 1.86 | 1.89 | 1.84 | 1.85 | 41,106 | |
| 02/20/2024 | 1.91 | 1.91 | 1.76 | 1.82 | 40,467 | |
| 02/16/2024 | 1.90 | 1.97 | 1.80 | 1.83 | 46,250 | |
| 02/15/2024 | 1.71 | 1.85 | 1.71 | 1.83 | 47,879 | |
| 02/14/2024 | 1.82 | 1.82 | 1.72 | 1.77 | 19,764 | |
| 02/13/2024 | 1.85 | 1.85 | 1.66 | 1.73 | 31,882 | |
| 02/12/2024 | 1.82 | 1.84 | 1.75 | 1.75 | 30,344 | |
| 02/09/2024 | 1.69 | 1.83 | 1.69 | 1.79 | 21,924 | |
| 02/08/2024 | 1.80 | 1.80 | 1.65 | 1.69 | 38,543 | |
| 02/07/2024 | 1.75 | 1.76 | 1.74 | 1.76 | 19,509 | |
| 02/06/2024 | 1.79 | 1.84 | 1.75 | 1.81 | 21,999 | |
| 02/05/2024 | 1.77 | 1.77 | 1.69 | 1.75 | 13,463 | |
| 02/02/2024 | 1.81 | 1.87 | 1.68 | 1.73 | 32,954 | |
| 02/01/2024 | 1.76 | 1.83 | 1.70 | 1.77 | 17,040 | |
| 01/31/2024 | 1.77 | 1.84 | 1.74 | 1.78 | 11,860 | |
| 01/30/2024 | 1.82 | 2.03 | 1.80 | 1.81 | 92,893 | |
| 01/29/2024 | 1.75 | 1.94 | 1.75 | 1.86 | 31,406 | |
| 01/26/2024 | 1.78 | 1.93 | 1.76 | 1.82 | 37,116 | |
| 01/25/2024 | 1.85 | 1.95 | 1.68 | 1.81 | 74,181 | |
| 01/24/2024 | 1.74 | 1.80 | 1.68 | 1.80 | 287,658 | |
| 01/23/2024 | 1.82 | 1.82 | 1.62 | 1.70 | 20,715 |
About Eledon Pharmaceuticals Stock history
Eledon Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eledon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eledon Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eledon Pharmaceuticals stock prices may prove useful in developing a viable investing in Eledon Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24.6 M | 25.9 M | |
| Net Loss | -31.1 M | -29.5 M |
Eledon Pharmaceuticals Quarterly Net Working Capital |
|
Eledon Pharmaceuticals Stock Technical Analysis
Eledon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Eledon Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eledon Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eledon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eledon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.36) | |||
| Treynor Ratio | (0.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eledon Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.Note that the Eledon Pharmaceuticals information on this page should be used as a complementary analysis to other Eledon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Eledon Stock analysis
When running Eledon Pharmaceuticals' price analysis, check to measure Eledon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eledon Pharmaceuticals is operating at the current time. Most of Eledon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eledon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eledon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eledon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Eledon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Return On Assets (0.30) | Return On Equity (0.48) |
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.